In 7 countries in the southern region of Africa, the estimated prevalence of HIV infection among adults was у20% by the end of the year 2000 [1] , which inevitably translated into a huge increase in the need for health care. Despite the gravity of the situation, research into the clinical aspects of HIV infection in southern Africa has not been prioritized, and the natural history of HIV infection in the region remains poorly characterized [2] . A clear understanding of how HIV affects the frequency and etiology of common illnesses facilitates good clinical management, points the way to interventions likely to reduce HIV infection-associated morbidity and mortality rates, and provides a firm basis for advocacy and planning.
We report a prospective cohort study that compared hospitalization and mortality rates between HIV-positive and HIV-negative South African gold miners. During follow-up, the prevalence of HIV infection was 24% in the workforce evaluated [3] , which primarily included male migrant workers living in single-sex hostels. Rates of trauma, sexually transmitted disease (STD), and silica-associated occupational disease are high [4, 5] . In recent years, the incidence of tuberculosis (TB) has increased to extremely high rates (figure 1) as a result of the combined effects of the HIV epidemic and the exposure to silica dust [8, 9] . The main aims of the study were to quantify the impact of HIV infection on the incidence and spectrum of diseases leading to hospitalization or death and to assess the scope for preventive interventions in this population. [6] . Workforce TB figures are from the Chamber of Mines, South Africa [7] .
METHODS

Study population and cohort selection.
In South Africa, gold miners are provided with private medical care at companyfunded hospitals and clinics. In the study hospital (Ernest Oppenheimer Hospital; Welkom), HIV testing has been offered, since 1991, to all patients presenting with HIV-associated conditions; consent is obtained from all miners, and pre-and posttest counseling is available. Hospital laboratory and payroll records were used to identify all current employees who had been tested for HIV since 1991. All men who had tested positive for HIV were included in the study, as were men who had tested negative for HIV because of an STD in 1994 or later. The cutoff date was imposed because of the increasing cumulative risk of new HIV infection as time passed after a negative HIV test result was obtained. Additional HIV testing to confirm negative status was not performed because of logistic and financial constraints. However, miners who presented with HIV-associated conditions during follow-up were asked to consent to retesting. Miners provided informed consent and received pre-and posttest counseling; they were excluded from the final analysis if they were subsequently found to be HIV positive. Participants who declined retesting were assumed to have remained HIV negative.
Cohort follow-up. Cohort subjects were observed for 12 months, starting in February 1998; we assessed admission to the study hospital and/or death. Admissions to other facilities were identified when emergency transfers were requested. However, because the town in which the study took place (Welkom) was geographically isolated, and because the hospital was the only source of free health care and sickness benefits, use of other inpatient facilities was minimal. Hospitalized participants were interviewed and examined according to a standardized protocol, and they were observed until discharge from the hospital or death. HIV-positive participants were asked to provide consent for measurement of their CD4 ϩ T lymphocyte count.
Gold miners who left employment or died were periodically identified by review of payroll, death benefit, and mortuary records. Routine heart and lung postmortem examinations for occupational diseases were performed for men who died in the hospital or in the vicinity of the mine. Postmortem findings were reviewed by the senior histopathologist at the National Centre for Occupational Health (Johannesburg).
Laboratory methods. CD4 ϩ T lymphocyte counts were measured by flow cytometry (FACScan; Becton Dickinson). Microscopic evaluation for TB was performed with auramine staining of concentrated specimens. Mycobacterial culture was performed using Lowenstein-Jensen slopes for sputum specimens and BACTEC (Becton Dickinson) liquid media for other specimens. Mycobacterium tuberculosis was identified with a colorimetric ribosomal RNA hybridization test (AccuProbe M. tuberculosis complex probe kit; Gen-Probe). Bacterial pathogens were identified by Gram staining and biochemical testing done after culture was performed with conventional media. Fungal identification was done by use of India ink contrast staining and microscopic evaluation, culture with Sabouraud media, and, for diluted blood or CSF specimens, latex agglutination testing for cryptococcal antigens. Pneumocystis carinii infection was diagnosed by microscopic evaluation of specimens stained with Grocott-Gomori methenamine-silver nitrate.
Case definitions. The main reason for admission to the hospital was determined for each patient on the basis of predefined case definitions (not detailed here) that incorporated clinical, radiologic, laboratory, and, if relevant, postmortem findings. The 1993 Centers for Disease Control and Prevention case definition for AIDS was followed, except that CD4 cell count criteria were not used [10] .
Ethical considerations. The study was approved by the ethics committees of the London School of Hygiene and Tropical Medicine (London) and the Ernest Oppenheimer Hospital (Welkom, South Africa). To maintain confidentiality, consent to participate in the study was obtained from hospitalized patients before their HIV test results were referenced. Additional testing and counseling were freely available.
Data analysis. Data were analyzed with Stata software, version 7.0 (Stata Corporation). Patient records were expanded into person-year follow-up records, according to each patient's age and reason for hospital admission. For all gold miners, separate records were created for each period between entry into the cohort and first admission (where relevant), between any subsequent hospital admissions, and then from last event to the end of the follow-up period. Poisson regression was used to calculate univariate incidence rate ratios (IRRs) from the expanded data set. For analyses in which multiple events were possible, random rate multipliers (assumed to follow a g distribution) were used to adjust rate ratio and 95% CI estimates for individual "frailty" effects, because rehospitalization rates were significantly greater than predicted by the Poisson distribution alone. Otherwise, IRRs were not adjusted. For variables with 12 categories, tests for trend were calculated using likelihood-ratio tests. The Mann-Whitney test was used to test differences in CD4 ϩ T lymphocyte counts for significance between subgroups of HIV-positive patients, according to admission and outcome categories.
RESULTS
The final cohort comprised 1792 HIV-positive men (38%) and 2970 HIV-negative men (62%). Baseline characteristics and cohort events are shown in table 1. The rate of leaving employment was significantly higher among HIV-positive employees than it was among HIV-negative employees (18.4 and 15.3 persons left employment per 100 person-years, respectively; IRR, 1.2; 95% CI, 1.03-1.4), but there were no significant differences in age or duration of employment.
Hospitalization rates among HIV-negative gold miners. There were 363 admissions to the hospital among HIV-negative men, for a rate of 14 hospitalizations per 100 person-years. Information about the hospitalizations is listed in table 2, and the main causes are illustrated in figure 2. Most admissions were related to trauma. Of the patients included in the final analysis, all of those with pneumonia and enteritis and all but 2 with TB (who declined additional testing) were confirmed to be HIV negative at admission.
Hospitalization rates among HIV-positive miners. For HIV-positive men, there were 599 admissions to the hospital. The overall rate was significantly higher than that for HIV-negative men (40.0 admissions to the hospital per 100 person-years; IRR, 2.9; 95% CI, 2.5-3.4). Infectious diseases were responsible for 70% of admissions to the hospital for HIV-positive men, as opposed to 30% of the admissions for HIV-negative men (P ! ). Incidence rates and rate ratios are shown in table 2, and .001 the main causes are illustrated in figure 2 .
The most frequent reasons for hospitalization of members of the HIV-positive cohort were TB (8.5 hospitalizations per 100 person-years), acute pneumonia (6.9 per 100 person-years), cryptococcosis (2.2 per 100 person-years), and trauma (6.0 per 100 person-years). P. carinii pneumonia (PCP) was uncommon, and there was only 1 diagnosis of HIV wasting syndrome. Admissions to the hospital because of TB, acute pneumonia, bronchitis, enteritis, soft-tissue infections, urinary tract infections, cryptococcosis, PCP, or conditions due to viral infections were each significantly associated with HIV infection (table 2) .
CD4 ϩ T lymphocyte counts are shown, according to cause and outcome of admission, in figure 3 . Not all HIV-positive men consented to provide additional blood samples to allow us to test for CD4 ϩ T lymphocyte counts. CD4 ϩ T lymphocyte counts in HIV-positive men with TB were significantly higher ( ) than were counts for patients with cryptococcal disease P ! .01 or other AIDS-defining diagnoses, but they did not differ significantly from the CD4 ϩ T lymphocyte counts for patients with pneumonia or enteritis. The highest CD4 ϩ T lymphocyte counts were in trauma and surgical patients.
Rehospitalizations. Rehospitalization rates were significantly higher than the incidence rate for first admissions (for HIV-positive men with and without a previous admission during the study, 75 and 35 rehospitalizations per 100 personyears, respectively; IRR, 2.18; 95% CI, 1.8-2.6). Infections were again the predominant cause (106 [70%] of 151 rehospitalizations and 317 [70%] of 448 first admissions), but pneumonia, rather than TB, was the most common cause among HIVpositive men (38 [25%] and 12 [8%] of the 151 recurrent admissions, respectively).
Rate and main causes of death. The rate of death was significantly higher among HIV-positive men than it was among HIV-negative men (5.5 and 0.6 deaths per 100 person-years, respectively; IRR, 9.2; 95% CI, 5.5-16.0). Cause of death, according to HIV infection status, is illustrated in figure 4 . The most common causes of death were cryptococcal disease, in HIV-positive men, and trauma, in HIV-negative men. Postmortem examination was performed for 51 (62%) of 82 HIVpositive patients who died and for 14 (93%) of 15 HIV-negative patients who died. HIV-positive men who died after being admitted to the hospital or within 2 weeks of discharge (defined as a fatal outcome for that admission) had significantly lower CD4 ϩ T lymphocyte counts than did those with nonfatal outcomes (respective median CD4 ϩ T lymphocyte counts, 36 and cells/L; ). Overall, 7.7% of HIV-positive pa-6 209 ϫ 10 P ! .001 tients and 3.6% of HIV-negative patients admitted to the hospital died ( ). P p .01 Disease-specific microbiologic data and clinical presentation. Data regarding relevant isolates recovered from patients Seroconversion in the HIV-negative group. As detailed in the Methods section, the interval between the date that a negative HIV test result was obtained and the start of the study was as long as 5 years for some men, so that some men had become HIV infected during this interval. As discussed in the Methods section, the admission and person-years data from men who were initially included in the HIV-negative arm of the cohort, but who were subsequently found to be HIV positive, were excluded from the final analysis. Altogether, 201 men (6% of the 3172 men initially selected into the HIV-negative cohort) and 187 (7% of a total of 2777 person-years observed for the initially selected HIV-negative cohort) were excluded because of a positive HIV test result obtained during the study period.
In most cases (123 [61%] of 201), the indication for additional HIV testing was for a symptomatic STD, and retesting was performed during outpatient clinic visits. For the remaining 78 patients (39%), however, the indication for retesting was because of admission to the hospital with an HIV-associated condition. Men with previously unidentified seroconversion to HIV-positive status accounted for 16 pneumonia admissions, 26 TB admissions, and 3 cryptococcal disease admissions. If we assume that hospitalization for HIV-associated diseases occurred at the same rate as that for the HIV-positive cohort, then the admission data from excluded men can be used to provide estimates of the total HIV prevalence for men in the initially selected HIV-negative cohort. For example, if the rate of admissions for cryptococcal disease was 2. estimated range of HIV prevalence of 5% to 11% suggests that most of the HIV-positive men were identified during the study year.
DISCUSSION
This study describes the impact of HIV infection on the incidence and spectrum of disease in South African gold miners. HIV infection greatly increased rates of hospitalization and death as a result of significantly increased rates of a range of different infectious diseases. TB was the single most common cause of hospitalization for the HIV-positive cohort. The grave consequences of the HIV epidemic on TB control at the workforce level are shown in figure 1 [6, 7] . Bacterial pneumonia, cryptococcal disease, and acute enteritis were also important HIV-associated opportunistic infections, with cryptococcal disease being the most common cause of death.
There are both similarities to and differences with other studies of HIV-associated disease in Africans [2, [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] . Greatly increased rates of TB and bacterial pneumonia are consistently associated with HIV disease in Africa, although there is an extra occupational component to TB in gold miners because of their exposure to silica dust [9] , and rates of pneumococcal disease in newly recruited miners were high even before the HIV epidemic [25] . Rates of acute pneumonia as variable as 9.3 [19] , 3.0 [23] , and 1.8 [18] cases per 100 person-years were observed in the placebo arms of 3 randomized, controlled trials involving HIV-positive Africans. Two of these trials investigated treatment with cotrimoxazole in Abidjan, Cote d'Ivoire [18, 19] , and the other trial studied pneumococcal vaccination in Ugandans [23] . Important differences in ascertainment are likely to have existed, however, because 2 of the studies included outpatients [19, 23] , whereas the study with the lowest rate of acute pneumonia included hospitalized patients only [18] .
Acute enteritis was the most common gastrointestinal com- [11, 13, 15, [18] [19] [20] , but this was not the case in the present study. The relative scarcity of gastrointestinal symptoms in the current study may reflect regional differences, or it may indicate that sanitation and water supplies in gold mines are unusually good for Africa. PCP and pulmonary Kaposi's sarcoma both occurred, albeit at low rates, and other AIDSdefining conditions, such as cerebral toxoplasmosis, cytomegalovirus disease, and disseminated Mycobacterium avium intracellulare, were notable for their absence, despite the availability of appropriate diagnostic facilities and expertise.
Overall mortality rates and the relative risk of death for HIVpositive gold miners in this study were within the range observed in other African cohorts [15, 21, 22, 24, 26] , but at the lower end. The high proportion of deaths due to cryptococcosis is noteworthy. Although there are no other regional incidence estimates, a high risk of cryptococcal disease appears to be a general feature of HIV in southern Africa [27] [28] [29] [30] that is not shared throughout the continent. Absolute incidence rates of cryptococcosis were !1 case per 100 person-years, and cryptococcosis was responsible for a much lower proportion of hospital admissions and deaths in both of the Abidjan cotrimoxazole trial cohorts [18, 19] and in rural Uganda [20] .
The main strengths of this study are its unusually large size, inclusion of both HIV-positive and HIV-negative cohorts, and unusually good diagnostic facilities plus a high coverage of postmortem examinations. These factors have enabled us to develop an unusually detailed description of the situation, with the impact of HIV infection clearly distinguished from that of HIV-negative disease. The main limitations of our report are the unusual population studied, which may well have altered the spectrum of disease seen, and the reliance on routine clinical services. We estimate that 6%-9% of the HIV-negative patients in our study had acquired HIV infection after their initial HIV test, but not all of these patients were identified and excluded during follow-up. This may have artificially increased our estimated rates of disease among HIV-negative patients, thereby underestimating the impact of HIV infection, although the potential for this was minimized by the high consent rates to retesting of patients with strongly HIV-related conditions. There is likely to have been a substantial "healthy worker" effect in our HIV-positive cohort, because the rate of leaving employment increased once workers became symptomatic, leading to reduced disease rates. On the other hand, our HIV-positive cohort was made up of prevalent (rather than incident) cases, including individuals identified through symptomatic HIV disease as well as STDs, resulting in an opposing bias toward inclusion of individuals with more-advanced HIV disease.
HIV prevalence in the study workforce was 24% by 1999 [3] . Our observed rates of hospital admission and death imply that, by 1999, general workforce death rates had tripled as a consequence of the HIV epidemic, and the rates of hospital admission had increased 1.5-fold. The scale of the impact of untreated HIV infection at such a high prevalence, and the huge toll from preventable opportunistic infections, such as TB [31] , bacterial infections [18, 19] , and cryptococcosis [32] , greatly exceed the level of uncertainty surrounding these estimates. After completion of this study, routine outpatient clinics offering isoniazid and cotrimoxazole prophylaxis have been started, and provision of additional therapies, including highly active antiretroviral drugs and prophylactic fluconazole, is now being considered. Increased access to the means of HIV diagnosis and treatment is urgently required throughout southern Africa.
